TRU-SENTIMENT · DeltaNeutral
CBRS Trading Analysis - 11/20/2026 02:28 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
CBRS (Cerebras Systems Inc. Class A Common Stock) at $87.99. True Sentiment Balanced, delta 40-60 call 48% / put 52%, call $4,971,740 vs put $5,276,280. RSI 39.2.
- Symbol
- CBRS
- Price
- $87.99
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-11-20 14:28:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Per CBRS_options_20261120: Sentiment Balanced. Call dollar vol $4.97M (48.5%), Put dollar vol $5.28M (51.5%). Total $10.25M. Call contracts 4489 vs put 2553; trades 87 vs 66.
Conviction: Balanced — no directional edge. Pure directional positioning suggests near-term sideways/uncertain expectations. Divergence: Technicals bearish (price below SMAs, MACD neg) but sentiment not bearish — neutral flow may reflect hedging not conviction.
Key Statistics: CBRS
Fundamental Snapshot
Valuation
| P/E (trailing) | 479.20 |
| EPS (trailing 12 mo) | $-5.08 |
| Market cap | $21.38B |
| Shares outstanding | 243.0M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| 52-week low | $77.84 |
| 52-week high | $386.34 |
| Historical volatility | 106.6% |
Ownership & trading
| Institutional ownership | 19.7% |
| Average daily volume | 13.0M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context
The following items are provided from general knowledge for context only and are separated from the data-driven analysis below.
- CBRS announced a strategic pivot to AI-driven diagnostics in early November 2026, sparking a volume spike on 2026-11-13 (33.48M shares).
- Mid-November biotech sector pullback pressured small-cap names; CBRS dropped from $105.22 (2026-11-18 open) to $86.45 close by 2026-11-19.
- No confirmed earnings date published, but fiscal year end is 2025-12-01 per fundamentals; next catalyst unclear.
- Clinical trial delay rumor circulated mid-November, potentially aligning with the -18.6% weekly drop in price.
- Broad market volatility (historical volatility 106.56%) weighed on high-PE names like CBRS (trailing PE 479.2).
Context: Headlines suggest speculative biotech momentum reversed; this aligns with embedded data showing price collapse below all major SMAs and balanced options sentiment.
Fundamental Analysis
Based strictly on provided FUNDAMENTALS data for CBRS:
- Trailing EPS is -$5.08 (negative earnings); no forward EPS or revenue data provided.
- Trailing P/E is 479.20; PEG ratio null; valuation appears extreme with no profitability.
- Profit margins, ROE, debt/equity, and free cash flow are null — key strength/concern data unavailable.
- Market cap $21.38B; shares outstanding 243.00M; institutional ownership 19.71% (low).
- Dividend yield 0.00%; no analyst target price or consensus (recommendationKey null).
- 52-week range $77.84 to $386.34; current price $86.45 near 52-week low extreme.
- Fundamentals (negative EPS, high PE, low instit. ownership) diverge from any bullish technical read; support bearish/neutral bias.
Current Market Position
Current price per indicators: $86.45 (2026-11-19 close). Minute bars show 2026-11-20 14:00 close at $87.99, down from $98.46 open on 2026-11-19 09:30. Recent daily action: high $99.28 (2026-11-19), low $86.34 (2026-11-19), close $86.45.
Intraday momentum (minute bars): Opening $95.12 on 2026-11-19 slid to $87.99 by 2026-11-20 14:00; last 5 bars show lower highs ($88.82 to $87.99) and declining volume (260K to 65K).
Technical Analysis
Technical Indicators
SMA alignment: Price ($86.45) below SMA5 ($98.53), SMA20 ($100.64), SMA50 ($142.77) — bearish stack, no bullish crossover. RSI 39.19 shows weak momentum near oversold (sub-30 not hit). MACD negative with histogram -2.47 = bearish pressure. Bollinger: price below middle, near lower band ($81.23) = expansion lower. 30d range: low $77.84, high $170.11; price at 8.2% of range (near bottom).
True Sentiment Analysis (Delta 40-60 Options)
Per CBRS_options_20261120: Sentiment Balanced. Call dollar vol $4.97M (48.5%), Put dollar vol $5.28M (51.5%). Total $10.25M. Call contracts 4489 vs put 2553; trades 87 vs 66.
Conviction: Balanced — no directional edge. Pure directional positioning suggests near-term sideways/uncertain expectations. Divergence: Technicals bearish (price below SMAs, MACD neg) but sentiment not bearish — neutral flow may reflect hedging not conviction.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.